CD7 CAR mRNA-LNP is a state-of-the-art messenger RNA (mRNA) lipid nanoparticle (LNP) system, specifically engineered for efficient in vitro and in vivo protein expression. This LNP encapsulates mRNA encoding the Chimeric Antigen Receptor (CAR) targeting CD7, serving as an excellent tool for investigating CAR-T cell therapy mechanisms and optimizing adoptive cell transfer protocols. Engineered with a proprietary lipid formulation for optimal mRNA encapsulation and delivery, it ensures high translation efficiency. Our LNP ensures uniform particle size, high encapsulation efficiency, stability, and effective delivery. Applications of CD7 CAR mRNA-LNP include monitoring CAR expression on transduced T cells and evaluating CAR-T cell functionality. Please note that this product is intended for research purposes only.
Inquiry
SPECIFIC INQUIRY
Clear AllInquiry
For Research Use Only. Not for Diagnostic or Treatment Applications.
Payload Type
CAR mRNA
Payload
CD7 CAR mRNA
Modification
Unmodified; N1-methyl-pseudouridine; 5-methoxyuridine; Other
